Skip to main content

Fractures or Dislocations

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Hamilton medical
Hamilton medicalSwitzerland - Bonaduz
1 program
INternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)N/A1 trial
Active Trials
NCT02150980Completed39,797Est. Nov 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Hamilton medicalINternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)

Clinical Trials (1)

Total enrollment: 39,797 patients across 1 trials

NCT02150980Hamilton medicalINternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)

INternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)

Start: Apr 2014Est. completion: Nov 202339,797 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.